LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge Microbial Research Concerto Biosciences pioneers breakthrough microbe-based products through advanced microbial research, utilizing the kChip discovery engine to identify promising microbes, prebiotics, and postbiotics. This innovative approach sets them apart in the biotechnology industry, presenting unique sales opportunities for businesses seeking cutting-edge solutions.

Expansion into Diverse Sectors With ongoing projects focusing on eczema-alleviation, vaginal health, gut health, and agriculture, Concerto Biosciences demonstrates a versatile product portfolio targeted at multiple sectors. This broad scope of research and product development presents sales opportunities for companies looking to partner with a biotech firm with diverse applications.

Tech-Savvy Approach Leveraging a tech stack that includes Sanity, Next.js, PWA, and Python among others, Concerto Biosciences showcases a strong technological foundation. This tech-savvy approach not only streamlines processes internally but also offers potential sales avenues to businesses seeking innovative solutions and partnerships in the biotech sector.

Solid Financial Backing Backed by $25M in funding and operating within a revenue range of $0-10M, Concerto Biosciences displays financial stability and growth potential. This financial backing provides assurance to potential partners and clients, presenting sales opportunities for companies looking to collaborate with a financially secure biotech research firm.

Market Differentiation and Competitive Positioning In a landscape with similar companies like Synlogic and Eligo Bioscience, Concerto Biosciences stands out with its unique approach to microbial research and product development. This differentiation enhances their competitive positioning and opens doors for sales partnerships with businesses seeking fresh and innovative solutions in the biotechnology research realm.

Similar companies to Concerto Biosciences

Concerto Biosciences Tech Stack

Concerto Biosciences uses 8 technology products and services including Sanity, Next.js, PWA, and more. Explore Concerto Biosciences's tech stack below.

  • Sanity
    Content Management System
  • Next.js
    Javascript Frameworks
  • PWA
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Vercel
    Platform As A Service
  • Python
    Programming Languages
  • Headless UI
    UI Frameworks
  • Linkedin
    Widgets

Media & News

Concerto Biosciences's Email Address Formats

Concerto Biosciences uses at least 1 format(s):
Concerto Biosciences Email FormatsExamplePercentage
First@concertobio.comJohn@concertobio.com
46%
Last@concertobio.comDoe@concertobio.com
4%
First@concertobio.comJohn@concertobio.com
46%
Last@concertobio.comDoe@concertobio.com
4%

Frequently Asked Questions

Where is Concerto Biosciences's headquarters located?

Minus sign iconPlus sign icon
Concerto Biosciences's main headquarters is located at Cambridge, MA US. The company has employees across 1 continents, including North America.

What is Concerto Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Concerto Biosciences's official website is concertobio.com and has social profiles on LinkedIn.

How much revenue does Concerto Biosciences generate?

Minus sign iconPlus sign icon
As of June 2024, Concerto Biosciences's annual revenue reached $1.8M.

What is Concerto Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Concerto Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Concerto Biosciences have currently?

Minus sign iconPlus sign icon
As of June 2024, Concerto Biosciences has approximately 32 employees across 1 continents, including North America. Key team members include Chief Operating Officer: B. C.Cofounder & Ceo: C. A.Cofounder And Chief Scientific Officer: J. K.. Explore Concerto Biosciences's employee directory with LeadIQ.

What industry does Concerto Biosciences belong to?

Minus sign iconPlus sign icon
Concerto Biosciences operates in the Biotechnology Research industry.

What technology does Concerto Biosciences use?

Minus sign iconPlus sign icon
Concerto Biosciences's tech stack includes SanityNext.jsPWAOpen GraphVercelPythonHeadless UILinkedin.

What is Concerto Biosciences's email format?

Minus sign iconPlus sign icon
Concerto Biosciences's email format typically follows the pattern of . Find more Concerto Biosciences email formats with LeadIQ.

How much funding has Concerto Biosciences raised to date?

Minus sign iconPlus sign icon
As of June 2024, Concerto Biosciences has raised $25M in funding. The last funding round occurred on Mar 22, 2022 for $25M.

When was Concerto Biosciences founded?

Minus sign iconPlus sign icon
Concerto Biosciences was founded in 2020.
Concerto Biosciences

Concerto Biosciences

Biotechnology ResearchMassachusetts, United States11-50 Employees

Concerto Biosciences examines the microbial world with unmatched experimental depth to discover breakthrough microbe-based products. We draw inspiration from microbial ecology: Microbes all around us work in concert to improve human health, enhance food quality, and boost crop yield. Designing products that recreate these capabilities requires an unprecedented understanding of how microbes behave together. Concerto unlocks this knowledge with kChip, a discovery engine that physically constructs millions of miniature, defined microbial communities simultaneously. By observing the behavior of each community, Concerto rapidly identifies the most promising microbes, prebiotics, and postbiotics for development into new products. In our first endeavor, Concerto constructed >6 million communities of skin-dwelling microbes to discover an eczema-alleviating “ensemble” of bacteria that pacifies pathogenic S. aureus. We have since initiated discovery projects in vaginal health, gut health, and agriculture. In partnership with a diverse array of biotech and biopharma companies, Concerto aims to unleash a new era of microbial research and a treasure trove of microbe-based products. 

Section iconCompany Overview

Headquarters
Cambridge, MA US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $25M

    Concerto Biosciences has raised a total of $25M of funding over 2 rounds. Their latest funding round was raised on Mar 22, 2022 in the amount of $25M.

  • $10M

    Concerto Biosciences's revenue is in the range of $10M

Section iconFunding & Financials

  • $25M

    Concerto Biosciences has raised a total of $25M of funding over 2 rounds. Their latest funding round was raised on Mar 22, 2022 in the amount of $25M.

  • $10M

    Concerto Biosciences's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.